Full Text View
Tabular View
No Study Results Posted
Related Studies
Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative ER(-)PR(-) Metastatic Breast Cancer
This study has been terminated.
( Low accrural )
Study NCT00303615   Information provided by Legacy Health System
First Received: March 16, 2006   Last Updated: October 17, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Metastatic Breast Cancer
Additional conditions recognized in this trial
Breast Neoplasms
More general conditions related to this trial
Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
Fluoxymesterone 10 mg
Anastrozole 1 mg
Additional drug interventions recognized in this trial
Anastrozole
Androgens
Estrogens
Fluoxymesterone
Progesterone
More general drug interventions related to this trial
Anabolic Agents
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Aromatase Inhibitors
Enzyme Inhibitors
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Progestins
Therapeutic Uses
Sponsors listed in this trial
Legacy Health System


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services